Llwytho...
AB084. Docetaxel therapy for hormone-sensitive prostate cancer—single center result
BACKGROUND: Androgen-deprivation therapy (ADT) has been the treatment for metastatic prostate cancer for more 75 years. We assessed whether concomitant treatment with ADT added to docetaxel would result in patients newly-diagnosed metastatic hormone-sensitive prostate cancer for longer overall survi...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Transl Androl Urol |
|---|---|
| Prif Awduron: | , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
AME Publishing Company
2015
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4708668/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3978/j.issn.2223-4683.2015.s084 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|